| 22/519 |
Communication and Information Management |
| 22/518 |
Breast Cancer Treatment |
| 22/516 |
Dr Hassan el Teraifi |
| 22/515 |
Complaints Contact |
| 22/513 |
Operating Theatres |
| 22/509 |
Staff |
| 22/495 |
Patients Treated (Revolade, Nplate, Doptelet, Tavlesse) |
| 22/494 |
Mobile Phone & Data Contracts |
| 22/493 |
Paxlovid |
| 22/490 |
Oncotype Use for Breast Cancer |
| 22/489 |
New Hospital Programme |
| 22/486 |
Microsoft 11 |
| 22/485 |
Drug Treatments |
| 22/483 |
Maternity Figures |
| 22/481 |
Haemophilia A |
| 22/478 |
Agency Usage |
| 22/477 |
PrEP Medication |
| 22/475 |
New Biologic Medications Within Dermatology |
| 22/474 |
Reinforced Autoclaved Aerated Concrete |
| 22/472 |
Stillbirth & Infant Deaths |
